Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis

Pharmacology

Volumn 92, Issue 5-6, 2014, Pages 257-264

  Li, Liren ^a   Liu, Suzhe ^a   Xu, Yue ^a   Zhang, Aixian ^a   Jiang, Jinxia ^a   Tan, Wei ^a   Xing, Jing ^a   Feng, Guijuan ^a   Liu, Hong ^a   Huo, Fangxin ^b   Tang, Qiyun ^c   Gu, Zhifeng ^a  

^a NANTONG UNIVERSITY   (China)

^b Maternal and Child Care Service Centre   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Colitis; Immunosuppression; Mesenchymal stem cells; Th17 cells; Treg cells

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNTING; CELL PROLIFERATION; COLON; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; LAMINA PROPRIA; MESENCHYMAL STEM CELL; MESENTERY LYMPH NODE; MODULATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN LYMPHOCYTE; TH17 CELL; UMBILICAL CORD; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL; ANIMAL EXPERIMENT; CELL CONTACT; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; CELL PROLIFERATION; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; LYMPH NODES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; UMBILICAL CORD;

EID: 84892978539     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000354883     Document Type: Article

References (33)

1. Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117: 514-521.
2. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533.
3. Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F: Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008; 28: 559-570.
4. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK: Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006; 203: 2785-2791.
5. Bianco P, Robey PG, Simmons PJ: Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313- 319.
6. Caplan AI: Mesenchymal stem cells. J Orthop Res 1991; 9: 641-650.
7. Caplan AI: Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213: 341-347.
8. Jones E, McGonagle D: Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford) 2008; 47: 126-131.
9. Paunescu V, Deak E, Herman D, Siska IR, Tanasie G, Bunu C, Anghel S, Tatu CA, Oprea TI, Henschler R, Ruster B, Bistrian R, Seifried E: In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J Cell Mol Med 2007; 11: 502- 508.
10. Spitkovsky D, Hescheler J: Adult mesenchymal stromal stem cells for therapeutic applications. Minim Invasive Ther Allied Technol 2008; 17: 79-90.
11. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S: Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009; 27: 1421- 1432.
12. Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, Hou Y, Lu L, Gilkeson GS, Silver RM, Zeng X, Shi S, Sun L: Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 2010; 19: 1502-1514.
13. Rao MS, Mattson MP: Stem cells and aging: Expanding the possibilities. Mech Ageing Dev 2001; 122: 713-734.
14. Mattson MP: Stem cells as therapeutics for neurodegenerative disorders Expert Rev Neurother 2001; 1: 267-273.
15. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, Vander Werff I, Troyer D, McIntosh KR: Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008; 26: 2865-2874.
16. Liang J, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L: Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease. Gut 2012; 61: 468-469.
17. Gu Z, Cao X, Jiang J, Li L, Da Z, Liu H, Cheng C: Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients. Cell Signal 2012; 24: 2307-2314.
18. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
19. MacPherson BR, Pfeiffer CJ: Experimental production of diffuse colitis in rats. Digestion 1978; 17: 135-150.
20. Leitao RF, Ribeiro RA, Bellaguarda EA, Macedo FD, Silva LR, Oria RB, Vale ML, Cunha FQ, Brito GA: Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol 2007; 59: 603-612.
21. Viney JL, MacDonald TT, Kilshaw PJ: T-cell receptor expression in intestinal intra-epithelial lymphocyte subpopulations of normal and athymic mice. Immunology 1989; 66: 583-587.
22. Bettelli E, Oukka M, Kuchroo VK: Th17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350.
23. Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr Opin Immunol 2006; 18: 349-356.
24. Tang Q, Bluestone JA: The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 2008; 9: 239-244.
25. Valencia X, Lipsky PE: CD4+CD25+Foxp3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 2007; 3: 619-626.
26. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W: A critical function for TGF- signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008; 9: 632-640.
27. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006; 441: 235- 238.
28. Weaver CT, Hatton RD, Mangan PR, Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852.
29. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR: TGF- -induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORt function. Nature 2008; 453: 236-240.
30. Li B, Greene MI: Special regulatory T-cell review: Foxp3 biochemistry in regulatory T cells - how diverse signals regulate suppression. Immunology 2008; 123: 17-19.
31. Svobodova E, Krulova M, Zajicova A, Pokorna K, Prochazkova J, Trosan P, Holan V: The role of mouse mesenchymal stem cells in differentiation of naive T cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. Stem Cells Dev 2012; 21: 901-910.
32. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M: Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009; 136: 978-989.
33. Baksh D, Yao R, Tuan RS: Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25: 1384-1392.